MENU
FEB 23, 2022 12:00 PM PST

Panel Presentation: Digital Solutions to Alleviate NASH Clinical Trial Challenges

C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract

The prevalence of NASH in global populations continues to expand in conjunction with the ongoing obesity and diabetes epidemic. Over the next decade, the disease is projected to become the leading indication for a liver transplant. With no current approved drug treatment interest from the pharmaceutical industry, efforts by regulatory authorities and investigators to facilitate the development of new therapies that decrease the severity of NASH remain very strong, despite the high rates of attrition seen within pipelines to date. This webinar will focus on the ability of digital technologies, including magnetic resonance imaging (MRI), magnetic resonance elastography (MRE), and whole slide imaging (WSI), to address some of these challenges. It will illustrate the ability of MRI and MRE to provide timely, high-quality, non-invasive solutions to enrolment and on the power of WSI to facilitate rapid complex workflows that assure consistent, high-quality assessments of primary efficacy endpoints by enabling expert histopathologists to interact remotely and in real-time.

Learning Objectives:

1. Identify challenges in NASH clinical trials.

2. Illustrate how digital technologies like MRI and MRE provide timely, high quality non-invasive solutions to NASH clinical trial enrollment.

3. Detail the power of whole slide imaging to facilitate rapid complex workflows In NASH clinical trials.


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
Loading Comments...
Show Resources